AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2019
Jan 7, 2019
33341_dirs_2019-01-07_6046e649-0dd5-4de7-8f98-3d0e244e3d27.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRC)
CIK: 0000070487
Period of Report: 2019-01-03
Reporting Person: Karas Kevin R (SVP Finance, CFO, Treas & Secy)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-01-03 | Employee Stock Option (right to buy) | $38.30 | A | 11162 | Acquired | 2029-01-03 | Common Stock (11162) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14016 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $10.75 | 2022-01-05 | Common Stock (26403) | 26403 | Direct |
| Employee Stock Option (right to buy) | $14.50 | 2023-01-07 | Common Stock (20088) | 20088 | Direct |
| Employee Stock Option (right to buy) | $18.80 | 2024-01-07 | Common Stock (5334) | 5334 | Direct |
| Employee Stock Option (right to buy) | $13.17 | 2025-01-06 | Common Stock (19313) | 19313 | Direct |
| Employee Stock Option (right to buy) | $15.23 | 2026-01-05 | Common Stock (20458) | 20458 | Direct |
| Employee Stock Option (right to buy) | $18.8 | 2027-01-04 | Common Stock (16728) | 16728 | Direct |
| Employee Stock Option (right to buy) | $36.8 | 2028-01-03 | Common Stock (11617) | 11617 | Direct |
Footnotes
F1: This option became fully exercisable on January 5, 2017.
F2: This option became fully exercisable on January 7, 2018.
F3: This option becomes fully exercisable on January 7, 2019.
F4: This option becomes fully exercisable on January 6, 2020.
F5: This option becomes fully exercisable on January 5, 2021.
F6: This option becomes fully exercisable on January 4, 2022.
F7: This option becomes fully exercisable on January 3, 2023.
F8: This option becomes fully exercisable on January 3, 2024.
More from NATIONAL RESEARCH CORP
Capital/Financing Update
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Earnings Release
2026
Apr 28
Regulatory Filings
2026
Apr 20